Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInvestment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Burning Rock Biotech (BNR) Consolidated Net Income: 2020-2025

Historic Consolidated Net Income for Burning Rock Biotech (BNR) over the last 6 years, with Sep 2025 value amounting to -$2.3 million.

  • Burning Rock Biotech's Consolidated Net Income rose 62.43% to -$2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.7 million, marking a year-over-year increase of 78.00%. This contributed to the annual value of -$45.9 million for FY2024, which is 49.80% up from last year.
  • As of Q3 2025, Burning Rock Biotech's Consolidated Net Income stood at -$2.3 million, which was down 76.56% from -$1.3 million recorded in Q2 2025.
  • Burning Rock Biotech's Consolidated Net Income's 5-year high stood at -$1.3 million during Q2 2025, with a 5-year trough of -$41.2 million in Q1 2022.
  • For the 3-year period, Burning Rock Biotech's Consolidated Net Income averaged around -$13.0 million, with its median value being -$14.7 million (2024).
  • In the last 5 years, Burning Rock Biotech's Consolidated Net Income plummeted by 59.78% in 2021 and then soared by 91.09% in 2025.
  • Over the past 5 years, Burning Rock Biotech's Consolidated Net Income (MRQ) stood at -$40.7 million in 2021, then rose by 16.17% to -$34.1 million in 2022, then rose by 28.51% to -$24.4 million in 2023, then skyrocketed by 66.27% to -$8.2 million in 2024, then soared by 71.89% to -$2.3 million in 2025.
  • Its Consolidated Net Income stands at -$2.3 million for Q3 2025, versus -$1.3 million for Q2 2025 and -$1.8 million for Q1 2025.